AIFM2 and metabolic disease: Ferroptosis is involved in the pathogenesis of EBI after SAH through various pathways, including the activation of ACSL4, iron metabolism disorders [90], and the down-regulation of GPX4 and ferroptosis suppressor protein 1 (FSP1) [91].